Sutro Biopharma, Inc. Announces Appointment of Heidi Hunter to Board of Directors, Member of the Audit Committee and Science and Technology Committee, Effective as of November 19, 2021
November 17, 2021 at 07:00 am EST
Sutro Biopharma, Inc. announced that Heidi Hunter has been appointed to the company's Board of Directors. Heidi Hunter has over 25 years of experience in biotech across the pharmaceutical value chain, from clinical and commercial development through to launch execution. She is currently President at Cardinal Health, where she leads the Specialty Solutions Business. Prior to Cardinal Health, Ms. Hunter was Senior Vice President of the Global Immunology Business Unit at UCB in Brussels. The company appointed Heidi Hunter as Class I director, member of the Audit Committee and Science and Technology Committee, effective as of November 19, 2021.